openPR Logo
Press release

Eczema Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

03-25-2025 09:57 AM CET | Health & Medicine

Press release from: The Business Research Company

Eczema

Eczema

What combination of drivers is leading to accelerated growth in the eczema market?
The increasing prevalence of autoimmune disorders is expected to propel the growth of the eczema market. Autoimmune disorders, including psoriasis, lupus, and rheumatoid arthritis, are on the rise due to genetic, environmental, and lifestyle factors. These disorders often involve an overactive immune system that can trigger skin conditions like eczema. For instance, in November 2024, Versorgungsatlas.de reported that a significant percentage of individuals in Germany were diagnosed with at least one autoimmune disease, creating a growing market for eczema treatments.

Get Your Eczema Market Report Here:
https://www.thebusinessresearchcompany.com/report/eczema-global-market-report

What is the projected compound annual growth rate (CAGR) of the eczema market from 2025 to 2034, and what factors influence it?
The eczema market has also expanded significantly, growing from $16.41 billion in 2024 to $17.81 billion in 2025 at a CAGR of 8.5%. The key historical growth factors include the rising prevalence of autoimmune diseases, increasing eczema cases, more regulatory approvals, higher air pollution levels, and an increasing burden of allergic reactions.

The eczema market is forecasted to grow steadily, reaching $24.35 billion by 2029 at a CAGR of 8.1%. Contributing factors include increasing demand for atopic dermatitis treatments, growing operational activities, heightened awareness of eczema, the rising use of biologics, and the expanding adoption of telemedicine platforms. Key industry trends involve strategic partnerships, emerging therapies, injectable drug innovations, and advancements in personalized medicine.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21179&type=smp

How are the latest trends influencing the growth of the eczema market?
In the eczema market, companies are focusing on innovative skincare products, such as eczema care creams, to meet consumer demand for advanced treatments. For example, in September 2024, Dove, a UK-based personal care brand, launched the Baby Dove Eczema Care range. The range includes products like Baby Dove Eczema Care Soothing Bath Treatment and Baby Dove Eczema Care Cream, both formulated with colloidal oatmeal (1.0%) to soothe irritation and hydrate sensitive skin, offering gentle relief for infants suffering from eczema.

What are the major segments of the eczema market and their role in driving growth?
The eczema market covered in this report is segmented -

1) By Type: Atopic Dermatitis, Contact Dermatitis, Seborrheic Dermatitis, Other Types
2) By Treatment Type: Topical Treatments, Oral Medications, Biologics, Phototherapy
3) By Age Group: Children, Adults, Elderly
4) By End User: Hospitals Or Clinics, Dermatology Centers, Home Care, Pharmacies

Subsegments:
1) By Atopic Dermatitis: Topical Steroids, Topical Calcineurin Inhibitors, Moisturizers, Biologic Therapies
2) By Contact Dermatitis: Topical Steroids, Antihistamines, Topical Immunosuppressants, Wet Compresses
3) By Seborrheic Dermatitis: Antifungal Creams or Shampoos, Topical Steroids, Medicated Shampoos, Topical Calcineurin Inhibitors
4) By Other Types: Allergic Dermatitis, Nummular Dermatitis, Neurodermatitis, Dyshidrotic Eczema

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21179

Which regions are key players in the growth of the eczema market?
North America was the largest region in the eczema market in 2024. The regions covered in the eczema market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the eczema market?
Major companies operating in the eczema market are Pfizer Inc., AbbieVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Amgen, Hoffmann-La Roche AG, Eli Lilly and Co., Siemens Healthineers AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc, Bausch Health Companies Inc., Galderma, Cadila Pharmaceuticals Ltd., LEO Pharma A/S, Almirall, Kyowa Kirin, Alliance Pharma Plc, Encore Dermatology Inc., Arcutis Inc

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21179&type=smp

What Is Covered In The Eczema Global Market Report?

•Market Size Forecast: Examine the eczema market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the eczema market for a structured understanding.
•Key Players Overview: Analyze major players in the eczema market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the eczema market.
•Segment Contributions: Evaluate how different segments drive overall growth in the eczema market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the eczema market.
•Industry Challenges: Identify potential risks and obstacles affecting the eczema market.
•Competitive Landscape: Review strategic developments in the eczema market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Eczema Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends here

News-ID: 3935637 • Views:

More Releases from The Business Research Company

Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additive Manufacturing Cell Market
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory. Projected Expansion of the Wire Arc Additive Manufacturing Cell Market The wire arc additive manufacturing cell
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for Arthritis Market Until 2029
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry. Projected Market Growth and Size of
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Development Service Market
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future. Projected Expansion and Market Size of
Competitive Landscape: Leading Companies and New Entrants in the Transient Elastography Market
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry. Projected Market Value and Growth of the Transient Elastography Market The transient elastography market is

All 5 Releases


More Releases for Eczema

Global Parents for Eczema Research (GPER) Announces 2025 Childhood Eczema Preven …
Santa Barbara, CA, September 9, 2025 - A decade ago, Global Parents for Eczema Research (GPER) was founded with a simple but powerful mission: to reduce the suffering of children with eczema and to give parents a voice in shaping research priorities. Today, GPER is carrying that mission forward by directly funding innovative science to make rapid progress towards a cure and prevention. GPER is excited to announce the recipients of
Hand Eczema Market Massive Growth opportunity Ahead
Introduction Hand eczema, a chronic inflammatory skin condition affecting the hands, is one of the most common occupational skin disorders worldwide. Characterized by itching, redness, scaling, and painful cracks, it can severely impair daily activities and quality of life. The condition is prevalent among healthcare workers, hairdressers, construction workers, and others exposed to irritants and allergens. With increasing awareness of skin health, growth in dermatological research, and the introduction of novel therapies
Codex Labs to Exhibit at the National Eczema Association's Eczema Expo 2025
Scottsdale, Ariz. - July 17th, 2025 - Codex Labs [https://www.codexlabscorp.com/], a biotech skincare company focused on microbiome-friendly solutions, is honored to participate in the National Eczema Association's Eczema Expo 2025 [https://nationaleczema.org/eczema-expo/?gad_source=1&gad_campaignid=22351487646&gbraid=0AAAAAB0npNbWbfjE80zPi-DhIw2YfY2qF&gclid=CjwKCAjw3f_BBhAPEiwAaA3K5GPLZHZHEl6Qy8xrAj3hEWhfW7WDsCE-7pymOFKmLfLmr43e1AAXYhoC90YQAvD_BwE]. Taking place from July 24th to 27th at the Grand Hyatt Scottsdale Resort, individuals impacted by eczema will gather to learn from world-class medical experts and community leaders. The goal of the event is to provide you with support,
Global Parents for Eczema Research (GPER) Awards Two Grants to Advance Childhood …
Santa Barbara, CA, October 15, 2024 - Global Parents for Eczema Research (GPER), a nonprofit organization dedicated to improving the lives of children suffering from eczema (atopic dermatitis, AD), announced the funding of two groundbreaking research projects as part of its 2024 Childhood Eczema Prevention Grant program. These grants will each provide up to $25,000 to support clinical research focused on preventing eczema in children. Eczema affects up to 20% of
Global Parents for Eczema Research (GPER) Announces Childhood Eczema Prevention …
Santa Barbara, CA, March 11, 2024 - Global Parents for Eczema Research (GPER) today announced the release of its Childhood Eczema Prevention Grant aimed at supporting innovative research studies focused on preventing pediatric atopic dermatitis (AD or "eczema"). This funding announcement is aimed at addressing the increasing prevalence of AD among children and at fostering research initiatives with the potential to mitigate the burden on children and families. "We are dedicated
Eczema Treatment Market During 2017 to 2025
Eczema, also referred as dermatitis or atopic dermatitis, is a disease which results in inflammation of the skin. Eczema is characterized by rash, red skin, and itchiness. The area of the skin involved may vary from small to the entire body. Few combination of factors such as genetical factor, abnormal function of immune system, environmental factor, defects in skin barrier, and activities may cause the skin to be extremely sensitive.